News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
262,861 Results
Type
Article (13649)
Company Profile (108)
Press Release (249104)
Section
Business (87984)
Career Advice (464)
Deals (15336)
Drug Delivery (64)
Drug Development (36557)
Employer Resources (49)
FDA (6275)
Job Trends (6190)
News (150107)
Policy (14016)
Tag
Academia (435)
Alliances (23171)
Alzheimer's disease (371)
Approvals (6285)
Artificial intelligence (74)
Bankruptcy (144)
Best Places to Work (4356)
Breast cancer (64)
Cancer (450)
Cardiovascular disease (47)
Career advice (406)
Cell therapy (62)
Clinical research (30631)
Collaboration (236)
Compensation (96)
COVID-19 (752)
C-suite (76)
Data (448)
Diabetes (64)
Diagnostics (1250)
Drug discovery (45)
Drug pricing (59)
Earnings (31636)
Events (37011)
Executive appointments (269)
FDA (6542)
Funding (155)
Gene therapy (72)
GLP-1 (314)
Government (1273)
Healthcare (3543)
Infectious disease (774)
Inflammatory bowel disease (50)
Interviews (58)
IPO (5849)
Job creations (2051)
Job search strategy (372)
Layoffs (170)
Legal (3416)
Lung cancer (64)
Manufacturing (113)
Medical device (1265)
Medtech (1267)
Mergers & acquisitions (9589)
Metabolic disorders (199)
Neuroscience (496)
NextGen: Class of 2025 (1581)
Non-profit (591)
Northern California (551)
Obesity (119)
Opinion (113)
Patents (70)
People (28660)
Pharmaceutical (67)
Phase I (7975)
Phase II (12950)
Phase III (11633)
Pipeline (230)
Policy (47)
Postmarket research (1400)
Preclinical (3181)
Radiopharmaceuticals (116)
Rare diseases (117)
Real estate (2631)
Regulatory (9931)
Research institute (563)
Resumes & cover letters (55)
Southern California (534)
Startups (1625)
United States (5355)
Vaccines (121)
Weight loss (86)
Date
Today (51)
Last 7 days (163)
Last 30 days (724)
Last 365 days (12369)
2025 (680)
2024 (12508)
2023 (14246)
2022 (19557)
2021 (20071)
2020 (19038)
2019 (14890)
2018 (11715)
2017 (13889)
2016 (13130)
2015 (15473)
2014 (12419)
2013 (10594)
2012 (11398)
2011 (11924)
2010 (10889)
Location
Africa (312)
Arizona (45)
Asia (19937)
Australia (2575)
California (1287)
Canada (722)
China (169)
Colorado (52)
Connecticut (54)
Europe (39022)
Florida (215)
Illinois (146)
Indiana (104)
Japan (59)
Kansas (53)
Maryland (189)
Massachusetts (1109)
Minnesota (71)
New Jersey (532)
New York (358)
North Carolina (319)
Northern California (551)
Pennsylvania (337)
South America (500)
Southern California (534)
Texas (169)
Virginia (50)
Washington State (85)
262,861 Results for "corvus pharmaceuticals".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Corvus Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference
January 7, 2025
·
1 min read
Press Releases
Corvus Pharmaceuticals Announces Data from Cohort 2 of Placebo-Controlled Phase 1 Clinical Trial of Soquelitinib for Atopic Dermatitis
January 14, 2025
·
10 min read
Press Releases
Corvus Pharmaceuticals Provides Business Update and Reports Third Quarter 2024 Financial Results
November 12, 2024
·
17 min read
Press Releases
Corvus Pharmaceuticals Announces Interim Data from Placebo-Controlled Phase 1 Clinical Trial of Soquelitinib for Atopic Dermatitis
December 18, 2024
·
13 min read
Business
Corvus Pharmaceuticals Provides Business Update and Reports First Quarter 2024 Financial Results
Corvus Pharmaceuticals, Inc. (Corvus or the Company) (Nasdaq: CRVS) (GLOBAL NEWSWIRE), a clinical-stage biopharmaceutical company, today provided a business update and reported financial results for the first quarter ended March 31, 2024.
May 6, 2024
·
19 min read
Biotech Bay
Corvus Pharmaceuticals to Present at the Jefferies Global Health Conference
Corvus Pharmaceuticals, Inc. today announced that Richard A. Miller, M.D., president and chief executive officer, and Jeffrey Arcara, chief business officer, will conduct one-on-one meetings with investors and present a corporate overview at the Jefferies Global Health Conference, which is being held in New York from June 5-7, 2024.
May 30, 2024
·
1 min read
Press Releases
Corvus Pharmaceuticals Announces New Preclinical Data Highlighting Potential of Soquelitinib to Treat Systemic Sclerosis
November 14, 2024
·
8 min read
Press Releases
Corvus Pharmaceuticals to Announce Interim Data from Placebo-Controlled Phase 1 Clinical Trial of Soquelitinib for Atopic Dermatitis on December 18, 2024
December 17, 2024
·
3 min read
Press Releases
Corvus Pharmaceuticals to Provide Business Update and Third Quarter 2024 Financial Results on November 12, 2024
November 5, 2024
·
1 min read
Press Releases
Corvus Pharmaceuticals Announces Publication of Biochemistry and Preclinical Data Demonstrating Potential of ITK Inhibition with Soquelitinib as a Novel Approach to Modulate Tumor Immunity
December 5, 2024
·
6 min read
1 of 26,287
Next
